Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFX-01 in community acquired pneumonia with suspected or confirmed COVID-19
2020-003486-19Phase 2Unknown
- Sponsor
- University of Dundee
- Start
- Aug 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in community-acquired pneumonia (CAP), pneumonia and coronavirus disease 2019 (COVID-19) comparing SFX-01 + best standard care with Placebo + best standard care (2 arms). Primary endpoint: Clinical status on 7-point ordinal scale. Status: unknown.
02
Drugs
sulforadex
03
Conditions
community-acquired pneumonia (CAP)pneumoniacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003486-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003486-19.